Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1952 2
1954 1
1955 1
1958 1
1959 1
1960 1
1961 1
1962 1
1964 2
1965 1
1990 3
1991 10
1992 33
1993 23
1994 27
1995 36
1996 35
1997 27
1998 38
1999 31
2000 55
2001 37
2002 41
2003 40
2004 28
2005 38
2006 30
2007 36
2008 37
2009 40
2010 38
2011 40
2012 46
2013 44
2014 75
2015 58
2016 55
2017 50
2018 66
2019 53
2020 50
2021 47
2022 61
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

1,228 results
Results by year
Filters applied: . Clear all
Page 1
Neurofibromatosis type 2.
Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR. Asthagiri AR, et al. Lancet. 2009 Jun 6;373(9679):1974-86. doi: 10.1016/S0140-6736(09)60259-2. Epub 2009 May 22. Lancet. 2009. PMID: 19476995 Free PMC article. Review.
Neurofibromatosis Type 2.
Ardern-Holmes S, Fisher G, North K. Ardern-Holmes S, et al. J Child Neurol. 2017 Jan;32(1):9-22. doi: 10.1177/0883073816666736. Epub 2016 Sep 29. J Child Neurol. 2017. PMID: 27655473 Review.
An update on the CNS manifestations of neurofibromatosis type 2.
Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S. Coy S, et al. Acta Neuropathol. 2020 Apr;139(4):643-665. doi: 10.1007/s00401-019-02029-5. Epub 2019 Jun 4. Acta Neuropathol. 2020. PMID: 31161239 Free PMC article. Review.
Neurofibromatosis type 2 and related disorders.
Halliday D, Parry A, Evans DG. Halliday D, et al. Curr Opin Oncol. 2019 Nov;31(6):562-567. doi: 10.1097/CCO.0000000000000579. Curr Opin Oncol. 2019. PMID: 31425178 Review.
Neurofibromatosis 2.
Hoa M, Slattery WH 3rd. Hoa M, et al. Otolaryngol Clin North Am. 2012 Apr;45(2):315-32, viii. doi: 10.1016/j.otc.2011.12.005. Otolaryngol Clin North Am. 2012. PMID: 22483819 Review.
Neurofibromatoses.
Jordan JT, Plotkin SR. Jordan JT, et al. Hematol Oncol Clin North Am. 2022 Feb;36(1):253-267. doi: 10.1016/j.hoc.2021.08.010. Epub 2021 Oct 27. Hematol Oncol Clin North Am. 2022. PMID: 34756486 Review.
Neurofibromatosis type 2.
Slattery WH. Slattery WH. Otolaryngol Clin North Am. 2015 Jun;48(3):443-60. doi: 10.1016/j.otc.2015.02.005. Otolaryngol Clin North Am. 2015. PMID: 26043141 Review.
Neurofibromatosis type 2.
Evans DG. Evans DG. Handb Clin Neurol. 2015;132:87-96. doi: 10.1016/B978-0-444-62702-5.00005-6. Handb Clin Neurol. 2015. PMID: 26564072 Review.
Neurofibromatosis type 2.
Evans GR, Lloyd SKW, Ramsden RT. Evans GR, et al. Adv Otorhinolaryngol. 2011;70:91-98. doi: 10.1159/000322482. Epub 2011 Feb 24. Adv Otorhinolaryngol. 2011. PMID: 21358190 Review.
1,228 results